BACKGROUND: It remains unknown whether diabetes mellitus (DM) is a risk factor for mild cognitive impairment (MCI). OBJECTIVE: To investigate the association of DM with MCI using a population-based case-control design. DESIGN: Population-based case-control study. SETTING: Academic research. PARTICIPANTS: Our study was conducted, among subjects aged 70 to 89 years on October 1, 2004, who were randomly selected from the Olmsted County (Minnesota) population. Main Outcome Measure We administered to all participants a neurologic examination, the Clinical Dementia Rating Scale, and a neuropsychological evaluation (including 9 tests in 4 cognitive domains) to diagnose normal cognition, MCI, or dementia. We assessed history of DM, DM treatment, and DM complications by interview, and we measured fasting blood glucose levels. History of DM was also confirmed using a medical records linkage system. RESULTS: We compared 329 subjects having MCI with 1640 subjects free of MCI and dementia. The frequency of DM was similar in subjects with MCI (20.1%) and in subjects without MCI (17.7%) (odds ratio [OR], 1.16; 95% confidence interval [CI], 0.85-1.57). However, MCI was associated with onset of DM before age 65 years (OR, 2.20; 95% CI, 1.29-3.73), DM duration of 10 years or longer (OR, 1.76; 95% CI, 1.16-2.68), treatment with insulin (OR, 2.01; 95% CI, 1.22-3.31), and the presence of DM complications (OR, 1.80; 95% CI, 1.13-2.89) after adjustment for age, sex, and education. Analyses using alternative definitions of DM yielded consistent findings. CONCLUSION: These findings suggest an association of MCI with earlier onset, longer duration, and greater severity of DM.
BACKGROUND: It remains unknown whether diabetes mellitus (DM) is a risk factor for mild cognitive impairment (MCI). OBJECTIVE: To investigate the association of DM with MCI using a population-based case-control design. DESIGN: Population-based case-control study. SETTING: Academic research. PARTICIPANTS: Our study was conducted, among subjects aged 70 to 89 years on October 1, 2004, who were randomly selected from the Olmsted County (Minnesota) population. Main Outcome Measure We administered to all participants a neurologic examination, the Clinical Dementia Rating Scale, and a neuropsychological evaluation (including 9 tests in 4 cognitive domains) to diagnose normal cognition, MCI, or dementia. We assessed history of DM, DM treatment, and DM complications by interview, and we measured fasting blood glucose levels. History of DM was also confirmed using a medical records linkage system. RESULTS: We compared 329 subjects having MCI with 1640 subjects free of MCI and dementia. The frequency of DM was similar in subjects with MCI (20.1%) and in subjects without MCI (17.7%) (odds ratio [OR], 1.16; 95% confidence interval [CI], 0.85-1.57). However, MCI was associated with onset of DM before age 65 years (OR, 2.20; 95% CI, 1.29-3.73), DM duration of 10 years or longer (OR, 1.76; 95% CI, 1.16-2.68), treatment with insulin (OR, 2.01; 95% CI, 1.22-3.31), and the presence of DM complications (OR, 1.80; 95% CI, 1.13-2.89) after adjustment for age, sex, and education. Analyses using alternative definitions of DM yielded consistent findings. CONCLUSION: These findings suggest an association of MCI with earlier onset, longer duration, and greater severity of DM.
Authors: P Fischer; S Jungwirth; S Zehetmayer; S Weissgram; S Hoenigschnabl; E Gelpi; W Krampla; K H Tragl Journal: Neurology Date: 2007-01-23 Impact factor: 9.910
Authors: P K Elias; M F Elias; R B D'Agostino; L A Cupples; P W Wilson; H Silbershatz; P A Wolf Journal: Diabetes Care Date: 1997-09 Impact factor: 19.112
Authors: D I Kaufer; J L Cummings; P Ketchel; V Smith; A MacMillan; T Shelley; O L Lopez; S T DeKosky Journal: J Neuropsychiatry Clin Neurosci Date: 2000 Impact factor: 2.198
Authors: Sarah E Vermeer; Tom Den Heijer; Peter J Koudstaal; Matthijs Oudkerk; Albert Hofman; Monique M B Breteler Journal: Stroke Date: 2003-02 Impact factor: 7.914
Authors: Jared P Reis; Lenore J Launer; James G Terry; Catherine M Loria; Adina Zeki Al Hazzouri; Stephen Sidney; Kristine Yaffe; David R Jacobs; Christopher T Whitlow; Na Zhu; J Jeffrey Carr Journal: Atherosclerosis Date: 2013-09-10 Impact factor: 5.162
Authors: Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; Bradley F Boeve; Robert J Ivnik; Vernon Shane Pankratz; Eric G Tangalos; Ronald C Petersen Journal: Alzheimer Dis Assoc Disord Date: 2010 Jan-Mar Impact factor: 2.703
Authors: Rosebud O Roberts; Yonas E Geda; David S Knopman; Bradley F Boeve; Teresa J H Christianson; V Shane Pankratz; Iftikhar J Kullo; Eric G Tangalos; Robert J Ivnik; Ronald C Petersen Journal: Alzheimers Dement Date: 2009-09 Impact factor: 21.566